Madrigal Pharma Adds Another Genetic Medicine to Its Drug Combo Strategy in MASHNews DeskMay 5, 20260 Madrigal Pharmaceuticals, maker of the first FDA-approved medicine for the fatty liver disease MASH, has been exploring combinations of that…